4
Changes in Ownership
Immix Biopharma, Inc. Filed Acc 0001493152-26-026425
Options or other derivatives
- CEO and Chairman acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rachman Ilya M · CEO and Chairman
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-22 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +500,000 | 500,000 | D |
Loading xslF345X06/ownership.xml…